Trial intelligence / Profile preview

BM-MSCs Transfer in STEMI Patients

NCT04421274Phase 3Completed

Sponsor
Affiliated Hospital of North Sichuan Medical College
Start
May 2008
Primary completion
Jul 2010
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of autologous bone-marrow mesenchymal stem cells in ST-segment elevation myocardial infarction (STEMI), sponsored by Affiliated Hospital of North Sichuan Medical College. Started May 2008; status: completed.

02

Drugs

autologous bone-marrow mesenchymal stem cells
03

Conditions

ST-segment elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT04421274.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04421274.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call